Christian Hopfer
Concepts (401)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance-Related Disorders | 37 | 2023 | 958 | 4.630 |
Why?
| Marijuana Abuse | 21 | 2024 | 209 | 4.060 |
Why?
| Cannabis | 12 | 2024 | 389 | 3.890 |
Why?
| Conduct Disorder | 16 | 2023 | 192 | 2.370 |
Why?
| Marijuana Use | 7 | 2024 | 158 | 1.780 |
Why?
| Alcohol Drinking | 16 | 2024 | 668 | 1.750 |
Why?
| Adolescent Behavior | 16 | 2020 | 495 | 1.660 |
Why?
| Marijuana Smoking | 9 | 2022 | 222 | 1.550 |
Why?
| Alcoholism | 17 | 2020 | 725 | 1.330 |
Why?
| Social Environment | 10 | 2014 | 301 | 1.290 |
Why?
| Tobacco Use Disorder | 11 | 2020 | 232 | 1.270 |
Why?
| Adolescent | 90 | 2024 | 18948 | 1.210 |
Why?
| Antisocial Personality Disorder | 15 | 2018 | 164 | 1.190 |
Why?
| Polymorphism, Single Nucleotide | 21 | 2022 | 2127 | 1.170 |
Why?
| Genetic Predisposition to Disease | 16 | 2022 | 2359 | 1.060 |
Why?
| Legislation, Drug | 4 | 2023 | 80 | 0.930 |
Why?
| Twins | 9 | 2024 | 247 | 0.910 |
Why?
| Siblings | 12 | 2020 | 235 | 0.870 |
Why?
| Medical Marijuana | 3 | 2020 | 103 | 0.870 |
Why?
| Analgesics, Opioid | 6 | 2020 | 785 | 0.810 |
Why?
| Dronabinol | 2 | 2020 | 120 | 0.800 |
Why?
| Risk-Taking | 7 | 2019 | 334 | 0.800 |
Why?
| Smoking | 16 | 2019 | 1556 | 0.790 |
Why?
| Genome-Wide Association Study | 14 | 2022 | 1376 | 0.780 |
Why?
| Young Adult | 36 | 2023 | 11094 | 0.750 |
Why?
| Opioid-Related Disorders | 5 | 2021 | 412 | 0.750 |
Why?
| Humans | 122 | 2024 | 122796 | 0.740 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 10 | 2018 | 242 | 0.740 |
Why?
| Female | 92 | 2023 | 63629 | 0.730 |
Why?
| Problem Behavior | 2 | 2018 | 88 | 0.730 |
Why?
| Male | 91 | 2023 | 59639 | 0.730 |
Why?
| Colorado | 23 | 2022 | 4325 | 0.720 |
Why?
| Cannabinol | 1 | 2019 | 3 | 0.700 |
Why?
| Diseases in Twins | 4 | 2014 | 181 | 0.670 |
Why?
| Hallucinogens | 1 | 2020 | 75 | 0.670 |
Why?
| Homeless Youth | 3 | 2008 | 15 | 0.670 |
Why?
| Criminals | 1 | 2018 | 27 | 0.650 |
Why?
| Substance Abuse, Intravenous | 3 | 2016 | 77 | 0.650 |
Why?
| Adult | 56 | 2024 | 32385 | 0.640 |
Why?
| Mental Disorders | 8 | 2021 | 952 | 0.630 |
Why?
| Colitis, Ulcerative | 1 | 2019 | 106 | 0.620 |
Why?
| Prescription Drug Misuse | 1 | 2017 | 36 | 0.610 |
Why?
| Sexual Behavior | 5 | 2019 | 470 | 0.600 |
Why?
| Cigarette Smoking | 1 | 2018 | 87 | 0.600 |
Why?
| Receptors, Nicotinic | 7 | 2016 | 309 | 0.590 |
Why?
| Longitudinal Studies | 24 | 2024 | 2599 | 0.580 |
Why?
| Prevalence | 11 | 2022 | 2442 | 0.560 |
Why?
| Genetic Linkage | 3 | 2008 | 328 | 0.560 |
Why?
| Prescription Drug Diversion | 1 | 2016 | 10 | 0.560 |
Why?
| Crohn Disease | 1 | 2019 | 200 | 0.540 |
Why?
| Genotype | 15 | 2019 | 1943 | 0.500 |
Why?
| Motivation | 2 | 2018 | 515 | 0.500 |
Why?
| Accidents, Traffic | 2 | 2018 | 179 | 0.480 |
Why?
| Body Mass Index | 3 | 2018 | 2144 | 0.480 |
Why?
| Inflammatory Bowel Diseases | 1 | 2018 | 290 | 0.480 |
Why?
| Receptors, Dopamine D2 | 4 | 2007 | 88 | 0.470 |
Why?
| Family Health | 1 | 2014 | 201 | 0.450 |
Why?
| Heroin Dependence | 2 | 2003 | 17 | 0.420 |
Why?
| Polymorphism, Genetic | 4 | 2016 | 666 | 0.420 |
Why?
| Genetic Variation | 5 | 2022 | 952 | 0.420 |
Why?
| Cross-Sectional Studies | 9 | 2023 | 4734 | 0.390 |
Why?
| Phenotype | 14 | 2020 | 3070 | 0.370 |
Why?
| Child Abuse | 6 | 2021 | 473 | 0.370 |
Why?
| Substance Abuse Detection | 2 | 2020 | 62 | 0.360 |
Why?
| Urban Population | 2 | 2012 | 425 | 0.360 |
Why?
| Prospective Studies | 9 | 2020 | 6704 | 0.350 |
Why?
| Impulsive Behavior | 4 | 2017 | 122 | 0.350 |
Why?
| Nurses, Community Health | 2 | 2019 | 35 | 0.350 |
Why?
| Surveys and Questionnaires | 12 | 2019 | 4882 | 0.350 |
Why?
| Biological Specimen Banks | 4 | 2019 | 107 | 0.350 |
Why?
| Substance Withdrawal Syndrome | 2 | 2019 | 159 | 0.340 |
Why?
| United States | 17 | 2022 | 13272 | 0.340 |
Why?
| United Kingdom | 3 | 2019 | 260 | 0.340 |
Why?
| Criminal Behavior | 2 | 2018 | 6 | 0.340 |
Why?
| Prenatal Care | 3 | 2019 | 261 | 0.340 |
Why?
| Haplotypes | 5 | 2009 | 482 | 0.330 |
Why?
| Comorbidity | 8 | 2016 | 1600 | 0.320 |
Why?
| Attention Deficit Disorder with Hyperactivity | 5 | 2022 | 374 | 0.320 |
Why?
| House Calls | 2 | 2019 | 144 | 0.320 |
Why?
| Cognition | 4 | 2020 | 1066 | 0.310 |
Why?
| Adolescent Development | 2 | 2019 | 85 | 0.310 |
Why?
| Sex Factors | 10 | 2017 | 1860 | 0.300 |
Why?
| Genetic Association Studies | 4 | 2021 | 383 | 0.300 |
Why?
| Receptors, Cannabinoid | 1 | 2006 | 13 | 0.300 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2006 | 43 | 0.300 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2006 | 51 | 0.300 |
Why?
| Health Surveys | 5 | 2012 | 468 | 0.300 |
Why?
| Case-Control Studies | 10 | 2019 | 3296 | 0.290 |
Why?
| Analgesics | 2 | 2020 | 163 | 0.290 |
Why?
| Home Care Services | 2 | 2019 | 226 | 0.290 |
Why?
| Multifactorial Inheritance | 3 | 2022 | 142 | 0.290 |
Why?
| Tandem Mass Spectrometry | 2 | 2020 | 423 | 0.290 |
Why?
| Multigene Family | 3 | 2013 | 200 | 0.280 |
Why?
| Homosexuality | 1 | 2006 | 17 | 0.280 |
Why?
| Bisexuality | 1 | 2006 | 15 | 0.280 |
Why?
| Receptors, Dopamine D1 | 1 | 2006 | 27 | 0.280 |
Why?
| Drug Prescriptions | 2 | 2018 | 271 | 0.280 |
Why?
| Mothers | 3 | 2019 | 728 | 0.280 |
Why?
| Tobacco Use | 2 | 2024 | 58 | 0.270 |
Why?
| Juvenile Delinquency | 4 | 2018 | 102 | 0.270 |
Why?
| Registries | 1 | 2014 | 2020 | 0.270 |
Why?
| Research Subjects | 2 | 2015 | 45 | 0.260 |
Why?
| Aggression | 4 | 2022 | 201 | 0.260 |
Why?
| Substance Abuse Treatment Centers | 3 | 2012 | 46 | 0.250 |
Why?
| Linkage Disequilibrium | 7 | 2021 | 279 | 0.250 |
Why?
| Genomics | 3 | 2020 | 714 | 0.250 |
Why?
| Genome | 1 | 2006 | 291 | 0.250 |
Why?
| Child Behavior Disorders | 3 | 2011 | 131 | 0.240 |
Why?
| Age of Onset | 5 | 2018 | 479 | 0.240 |
Why?
| Obesity | 1 | 2017 | 2786 | 0.240 |
Why?
| Internationality | 2 | 2022 | 158 | 0.240 |
Why?
| Interview, Psychological | 4 | 2013 | 95 | 0.240 |
Why?
| Alleles | 8 | 2018 | 852 | 0.230 |
Why?
| Heroin | 1 | 2003 | 17 | 0.230 |
Why?
| Adoption | 1 | 2003 | 38 | 0.230 |
Why?
| Gene Frequency | 6 | 2016 | 522 | 0.230 |
Why?
| Genetic Loci | 3 | 2022 | 296 | 0.230 |
Why?
| Narcotics | 1 | 2003 | 53 | 0.220 |
Why?
| Child | 22 | 2022 | 19561 | 0.220 |
Why?
| Nerve Tissue Proteins | 5 | 2013 | 557 | 0.220 |
Why?
| Models, Genetic | 6 | 2010 | 599 | 0.220 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 75 | 0.210 |
Why?
| Incidence | 4 | 2018 | 2527 | 0.200 |
Why?
| Age Factors | 6 | 2014 | 3114 | 0.200 |
Why?
| Risk Factors | 11 | 2022 | 9381 | 0.200 |
Why?
| Public Health | 1 | 2006 | 480 | 0.200 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 57 | 0.190 |
Why?
| Cannabinoid Receptor Agonists | 1 | 2020 | 30 | 0.190 |
Why?
| Twins, Monozygotic | 4 | 2010 | 215 | 0.180 |
Why?
| Monoamine Oxidase | 2 | 2013 | 25 | 0.180 |
Why?
| Depression | 3 | 2022 | 1190 | 0.180 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 141 | 0.180 |
Why?
| Health Risk Behaviors | 1 | 2019 | 15 | 0.180 |
Why?
| Pain, Postoperative | 2 | 2019 | 214 | 0.180 |
Why?
| Autistic Disorder | 1 | 2022 | 176 | 0.180 |
Why?
| Nausea | 1 | 2020 | 110 | 0.180 |
Why?
| Maternal Health | 1 | 2019 | 45 | 0.180 |
Why?
| Behavior, Addictive | 1 | 2020 | 79 | 0.170 |
Why?
| Minisatellite Repeats | 1 | 2019 | 38 | 0.170 |
Why?
| Physician Incentive Plans | 1 | 2018 | 7 | 0.170 |
Why?
| Expressed Emotion | 1 | 2018 | 21 | 0.170 |
Why?
| HIV Infections | 1 | 2013 | 2532 | 0.170 |
Why?
| Multimodal Imaging | 1 | 2019 | 102 | 0.170 |
Why?
| Calcium-Transporting ATPases | 1 | 2018 | 36 | 0.170 |
Why?
| Mortality, Premature | 1 | 2018 | 15 | 0.170 |
Why?
| Chromatography, Liquid | 1 | 2020 | 356 | 0.160 |
Why?
| Digestive System Surgical Procedures | 1 | 2019 | 93 | 0.160 |
Why?
| Feeding and Eating Disorders | 1 | 2020 | 127 | 0.160 |
Why?
| Pregnancy | 5 | 2022 | 5854 | 0.160 |
Why?
| Cannabinoids | 2 | 2017 | 120 | 0.160 |
Why?
| Suicide | 2 | 2021 | 498 | 0.150 |
Why?
| Urine | 1 | 2017 | 65 | 0.150 |
Why?
| Receptors, Opioid, mu | 2 | 2015 | 52 | 0.150 |
Why?
| Bioethics | 1 | 2017 | 13 | 0.150 |
Why?
| Analgesics, Non-Narcotic | 1 | 2019 | 122 | 0.150 |
Why?
| Biomedical Research | 2 | 2014 | 630 | 0.150 |
Why?
| Unsafe Sex | 2 | 2016 | 59 | 0.150 |
Why?
| Middle Aged | 11 | 2019 | 28563 | 0.150 |
Why?
| Infant, Newborn | 4 | 2020 | 5430 | 0.150 |
Why?
| Depressive Disorder, Major | 2 | 2020 | 309 | 0.150 |
Why?
| Counseling | 1 | 2020 | 364 | 0.150 |
Why?
| Physicians, Family | 1 | 2018 | 242 | 0.140 |
Why?
| Neuropsychological Tests | 2 | 2020 | 1072 | 0.140 |
Why?
| Mental Health | 1 | 2022 | 571 | 0.140 |
Why?
| Administration, Oral | 1 | 2019 | 786 | 0.140 |
Why?
| Lipids | 1 | 2020 | 614 | 0.140 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2016 | 39 | 0.140 |
Why?
| Gene-Environment Interaction | 2 | 2020 | 206 | 0.140 |
Why?
| Brain | 2 | 2019 | 2540 | 0.140 |
Why?
| Self Report | 2 | 2018 | 730 | 0.140 |
Why?
| Drug Storage | 1 | 2016 | 61 | 0.140 |
Why?
| Mental Competency | 1 | 2015 | 26 | 0.140 |
Why?
| Patient Admission | 2 | 2012 | 195 | 0.140 |
Why?
| Interviews as Topic | 3 | 2007 | 601 | 0.140 |
Why?
| Plasma | 1 | 2017 | 223 | 0.140 |
Why?
| Brain Mapping | 1 | 2019 | 552 | 0.130 |
Why?
| Drug Overdose | 2 | 2018 | 273 | 0.130 |
Why?
| Surgical Procedures, Operative | 1 | 2018 | 227 | 0.130 |
Why?
| Neuroimaging | 1 | 2017 | 261 | 0.130 |
Why?
| Life Change Events | 1 | 2016 | 138 | 0.130 |
Why?
| Image Processing, Computer-Assisted | 1 | 2019 | 739 | 0.130 |
Why?
| Exploratory Behavior | 2 | 2013 | 93 | 0.130 |
Why?
| Automobile Driving | 1 | 2016 | 129 | 0.130 |
Why?
| Informed Consent | 1 | 2015 | 166 | 0.130 |
Why?
| Pregnancy Complications | 1 | 2019 | 462 | 0.120 |
Why?
| Twins, Dizygotic | 3 | 2010 | 183 | 0.120 |
Why?
| Patient Satisfaction | 1 | 2018 | 632 | 0.120 |
Why?
| Proteomics | 1 | 2020 | 890 | 0.120 |
Why?
| Medicine | 1 | 2016 | 112 | 0.120 |
Why?
| Netherlands | 1 | 2014 | 74 | 0.120 |
Why?
| Cohort Studies | 6 | 2021 | 5294 | 0.120 |
Why?
| Practice Patterns, Physicians' | 3 | 2019 | 1267 | 0.120 |
Why?
| Genetic Testing | 1 | 2016 | 400 | 0.120 |
Why?
| Regression Analysis | 3 | 2019 | 1018 | 0.120 |
Why?
| Receptors, GABA-A | 1 | 2014 | 88 | 0.120 |
Why?
| Time Factors | 3 | 2019 | 6682 | 0.120 |
Why?
| Aged | 5 | 2018 | 20495 | 0.110 |
Why?
| Conflict of Interest | 1 | 2014 | 138 | 0.110 |
Why?
| Condoms | 1 | 2013 | 123 | 0.110 |
Why?
| Temperament | 1 | 2013 | 68 | 0.110 |
Why?
| Patient Safety | 1 | 2016 | 302 | 0.110 |
Why?
| Emotions | 2 | 2021 | 524 | 0.110 |
Why?
| Receptors, Oxytocin | 1 | 2012 | 25 | 0.110 |
Why?
| Family Conflict | 1 | 2012 | 40 | 0.110 |
Why?
| Severity of Illness Index | 2 | 2019 | 2784 | 0.100 |
Why?
| Socioeconomic Factors | 2 | 2013 | 1158 | 0.100 |
Why?
| Sexual Partners | 1 | 2013 | 184 | 0.100 |
Why?
| Family Relations | 1 | 2012 | 88 | 0.100 |
Why?
| Educational Status | 1 | 2013 | 448 | 0.100 |
Why?
| Multivariate Analysis | 2 | 2012 | 1531 | 0.100 |
Why?
| Ethanol | 2 | 2012 | 584 | 0.090 |
Why?
| Dizziness | 1 | 2010 | 71 | 0.090 |
Why?
| Pentachlorophenol | 1 | 1990 | 22 | 0.090 |
Why?
| Logistic Models | 4 | 2019 | 1995 | 0.090 |
Why?
| Psychometrics | 3 | 2009 | 672 | 0.090 |
Why?
| Hospitalization | 1 | 2019 | 1914 | 0.090 |
Why?
| Biomarkers | 1 | 2020 | 3662 | 0.090 |
Why?
| Models, Statistical | 2 | 2010 | 651 | 0.090 |
Why?
| Receptor, Cannabinoid, CB1 | 1 | 2009 | 29 | 0.090 |
Why?
| Magnetic Resonance Imaging | 2 | 2019 | 3264 | 0.090 |
Why?
| Sample Size | 2 | 2022 | 135 | 0.090 |
Why?
| Suicidal Ideation | 3 | 2021 | 413 | 0.090 |
Why?
| Genetic Markers | 2 | 2007 | 358 | 0.090 |
Why?
| Taq Polymerase | 2 | 2006 | 10 | 0.080 |
Why?
| Models, Theoretical | 1 | 2013 | 574 | 0.080 |
Why?
| Child Abuse, Sexual | 1 | 2009 | 82 | 0.080 |
Why?
| Retrospective Studies | 8 | 2021 | 13433 | 0.080 |
Why?
| Primary Health Care | 1 | 2018 | 1625 | 0.080 |
Why?
| Emergency Service, Hospital | 1 | 2019 | 1922 | 0.080 |
Why?
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 12 | 0.080 |
Why?
| Quality of Life | 1 | 2019 | 2457 | 0.080 |
Why?
| Environment | 4 | 2012 | 357 | 0.080 |
Why?
| Methylphenidate | 2 | 2004 | 37 | 0.080 |
Why?
| Stress, Psychological | 1 | 2016 | 1021 | 0.080 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 17 | 0.080 |
Why?
| Family | 4 | 2016 | 595 | 0.080 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2007 | 64 | 0.080 |
Why?
| Statistics as Topic | 1 | 2008 | 314 | 0.070 |
Why?
| Risk | 2 | 2020 | 890 | 0.070 |
Why?
| 3' Untranslated Regions | 1 | 2007 | 147 | 0.070 |
Why?
| Fathers | 1 | 2006 | 47 | 0.070 |
Why?
| Child of Impaired Parents | 1 | 2006 | 43 | 0.070 |
Why?
| Microsatellite Repeats | 1 | 2006 | 147 | 0.070 |
Why?
| Cheek | 1 | 2006 | 16 | 0.070 |
Why?
| Lysergic Acid Diethylamide | 1 | 2006 | 3 | 0.070 |
Why?
| Social Facilitation | 1 | 2006 | 9 | 0.070 |
Why?
| Sodium Oxybate | 1 | 2006 | 5 | 0.070 |
Why?
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2006 | 12 | 0.070 |
Why?
| Central Nervous System Stimulants | 2 | 2004 | 143 | 0.070 |
Why?
| Alcohol-Related Disorders | 1 | 2007 | 116 | 0.070 |
Why?
| Poverty | 2 | 2019 | 475 | 0.070 |
Why?
| Schizophrenia | 2 | 2022 | 544 | 0.070 |
Why?
| Genetics, Population | 1 | 2007 | 212 | 0.070 |
Why?
| Parents | 2 | 2004 | 1256 | 0.070 |
Why?
| Parenting | 1 | 2009 | 267 | 0.070 |
Why?
| Protein Kinase C | 1 | 2007 | 314 | 0.070 |
Why?
| Religion | 1 | 2006 | 70 | 0.070 |
Why?
| Methamphetamine | 1 | 2006 | 52 | 0.070 |
Why?
| Beta Rhythm | 1 | 2004 | 12 | 0.060 |
Why?
| Suicide, Attempted | 1 | 2008 | 331 | 0.060 |
Why?
| Ketamine | 1 | 2006 | 104 | 0.060 |
Why?
| Universities | 1 | 2007 | 356 | 0.060 |
Why?
| Pain Management | 2 | 2019 | 306 | 0.060 |
Why?
| Marriage | 1 | 2004 | 112 | 0.060 |
Why?
| Data Interpretation, Statistical | 3 | 2010 | 345 | 0.060 |
Why?
| Drug Tolerance | 1 | 2003 | 77 | 0.060 |
Why?
| Genome, Human | 2 | 2020 | 392 | 0.060 |
Why?
| Infant | 3 | 2021 | 8523 | 0.050 |
Why?
| Membrane Transport Proteins | 1 | 2003 | 137 | 0.050 |
Why?
| Loneliness | 1 | 2022 | 34 | 0.050 |
Why?
| Europe | 1 | 2022 | 369 | 0.050 |
Why?
| Predictive Value of Tests | 2 | 2021 | 1947 | 0.050 |
Why?
| Sensitivity and Specificity | 2 | 2021 | 1855 | 0.050 |
Why?
| Models, Psychological | 2 | 2016 | 321 | 0.050 |
Why?
| Personality Assessment | 2 | 2013 | 83 | 0.050 |
Why?
| Calibration | 1 | 2021 | 140 | 0.050 |
Why?
| Electroencephalography | 1 | 2003 | 408 | 0.050 |
Why?
| Membrane Glycoproteins | 1 | 2003 | 462 | 0.050 |
Why?
| Proportional Hazards Models | 2 | 2018 | 1184 | 0.050 |
Why?
| Follow-Up Studies | 2 | 2019 | 4768 | 0.050 |
Why?
| Bipolar Disorder | 1 | 2022 | 207 | 0.050 |
Why?
| Polymerase Chain Reaction | 2 | 2014 | 1021 | 0.050 |
Why?
| Bayes Theorem | 1 | 2021 | 363 | 0.050 |
Why?
| Minnesota | 1 | 2020 | 143 | 0.040 |
Why?
| Interrupted Time Series Analysis | 1 | 2019 | 46 | 0.040 |
Why?
| Infant, Small for Gestational Age | 1 | 2019 | 74 | 0.040 |
Why?
| Dangerous Behavior | 1 | 2018 | 20 | 0.040 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 95 | 0.040 |
Why?
| Drug Utilization Review | 1 | 2019 | 65 | 0.040 |
Why?
| Electronic Mail | 1 | 2018 | 59 | 0.040 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2019 | 146 | 0.040 |
Why?
| Atmospheric Pressure | 1 | 2017 | 19 | 0.040 |
Why?
| Safety-net Providers | 1 | 2019 | 106 | 0.040 |
Why?
| Factor Analysis, Statistical | 2 | 2010 | 283 | 0.040 |
Why?
| Statistics, Nonparametric | 2 | 2012 | 416 | 0.040 |
Why?
| Preoperative Period | 1 | 2018 | 112 | 0.040 |
Why?
| Limit of Detection | 1 | 2017 | 59 | 0.040 |
Why?
| Epidemics | 1 | 2018 | 76 | 0.040 |
Why?
| Child, Preschool | 2 | 2022 | 9755 | 0.040 |
Why?
| Treatment Outcome | 2 | 2019 | 9692 | 0.040 |
Why?
| Executive Function | 1 | 2021 | 406 | 0.040 |
Why?
| Postoperative Period | 1 | 2018 | 317 | 0.040 |
Why?
| Transcriptome | 1 | 2022 | 774 | 0.040 |
Why?
| Pregnancy Outcome | 1 | 2019 | 364 | 0.040 |
Why?
| Gene Expression | 2 | 2016 | 1506 | 0.040 |
Why?
| Psychiatric Status Rating Scales | 2 | 2010 | 531 | 0.040 |
Why?
| Chromosome Mapping | 2 | 2008 | 518 | 0.040 |
Why?
| Cause of Death | 1 | 2018 | 389 | 0.040 |
Why?
| California | 1 | 2017 | 387 | 0.040 |
Why?
| Nicotine | 2 | 2010 | 276 | 0.040 |
Why?
| CD56 Antigen | 1 | 2016 | 35 | 0.040 |
Why?
| Mortality | 1 | 2018 | 317 | 0.040 |
Why?
| Violence | 1 | 2018 | 225 | 0.030 |
Why?
| Quality Control | 1 | 2016 | 165 | 0.030 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2017 | 493 | 0.030 |
Why?
| Potassium Channels | 1 | 2016 | 137 | 0.030 |
Why?
| Reward | 1 | 2017 | 214 | 0.030 |
Why?
| Anxiety | 1 | 2022 | 888 | 0.030 |
Why?
| Thoracic Surgical Procedures | 1 | 2016 | 65 | 0.030 |
Why?
| Heterozygote | 1 | 2016 | 270 | 0.030 |
Why?
| Psychology, Adolescent | 1 | 2015 | 64 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2003 | 1519 | 0.030 |
Why?
| Cell Adhesion Molecules | 1 | 2016 | 188 | 0.030 |
Why?
| Sleep | 1 | 2021 | 722 | 0.030 |
Why?
| Likelihood Functions | 1 | 2015 | 139 | 0.030 |
Why?
| Aging | 1 | 2004 | 1694 | 0.030 |
Why?
| Demography | 1 | 2015 | 290 | 0.030 |
Why?
| Disclosure | 1 | 2014 | 109 | 0.030 |
Why?
| Cesarean Section | 1 | 2016 | 184 | 0.030 |
Why?
| Arsenites | 1 | 1993 | 6 | 0.030 |
Why?
| Arsenic Poisoning | 1 | 1993 | 8 | 0.030 |
Why?
| Sexually Transmitted Diseases | 1 | 2016 | 218 | 0.030 |
Why?
| Arsenicals | 1 | 1993 | 26 | 0.030 |
Why?
| Gluconeogenesis | 1 | 1993 | 66 | 0.030 |
Why?
| Chelating Agents | 1 | 1993 | 75 | 0.030 |
Why?
| Cotinine | 1 | 2013 | 78 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2016 | 427 | 0.030 |
Why?
| Risk Assessment | 2 | 2015 | 3213 | 0.030 |
Why?
| Child Behavior | 2 | 2005 | 238 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 1287 | 0.030 |
Why?
| Kidney Tubules | 1 | 1993 | 128 | 0.030 |
Why?
| Psychological Theory | 1 | 2013 | 101 | 0.030 |
Why?
| Privacy | 1 | 2012 | 31 | 0.030 |
Why?
| Students | 1 | 2017 | 529 | 0.030 |
Why?
| Probability | 1 | 2013 | 316 | 0.030 |
Why?
| Pedigree | 1 | 2013 | 492 | 0.030 |
Why?
| Carrier Proteins | 1 | 2016 | 740 | 0.030 |
Why?
| Software | 1 | 2016 | 631 | 0.030 |
Why?
| Disease Progression | 1 | 2018 | 2546 | 0.020 |
Why?
| Attitude of Health Personnel | 1 | 2018 | 1012 | 0.020 |
Why?
| Antidotes | 1 | 1993 | 160 | 0.020 |
Why?
| Reproducibility of Results | 2 | 2009 | 2977 | 0.020 |
Why?
| Exercise | 1 | 2021 | 1743 | 0.020 |
Why?
| Pleasure | 1 | 2010 | 19 | 0.020 |
Why?
| Sensation | 1 | 2010 | 46 | 0.020 |
Why?
| Chromatography, Gas | 1 | 1990 | 32 | 0.020 |
Why?
| Prognosis | 1 | 2018 | 3563 | 0.020 |
Why?
| Rats, Inbred Strains | 1 | 1990 | 392 | 0.020 |
Why?
| Negotiating | 1 | 2009 | 23 | 0.020 |
Why?
| Membrane Proteins | 1 | 2016 | 1093 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2012 | 410 | 0.020 |
Why?
| Patient Discharge | 1 | 2016 | 842 | 0.020 |
Why?
| Psychological Tests | 1 | 2010 | 131 | 0.020 |
Why?
| Molecular Structure | 1 | 1990 | 463 | 0.020 |
Why?
| Epistasis, Genetic | 1 | 2009 | 73 | 0.020 |
Why?
| Personality Inventory | 1 | 2009 | 137 | 0.020 |
Why?
| Mouth Mucosa | 1 | 2007 | 81 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1003 | 0.020 |
Why?
| Parent-Child Relations | 1 | 2009 | 246 | 0.020 |
Why?
| Odds Ratio | 1 | 2009 | 1043 | 0.020 |
Why?
| Analysis of Variance | 1 | 2009 | 1329 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 783 | 0.020 |
Why?
| Rats | 2 | 1993 | 5426 | 0.020 |
Why?
| Confidence Intervals | 1 | 2006 | 339 | 0.020 |
Why?
| Linear Models | 1 | 2007 | 854 | 0.020 |
Why?
| Reference Values | 1 | 2006 | 789 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 6845 | 0.020 |
Why?
| Frontal Lobe | 1 | 2004 | 152 | 0.010 |
Why?
| Research Design | 1 | 2009 | 1002 | 0.010 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2003 | 40 | 0.010 |
Why?
| Schools | 1 | 2006 | 428 | 0.010 |
Why?
| Housing | 1 | 2004 | 125 | 0.010 |
Why?
| Chi-Square Distribution | 1 | 2004 | 551 | 0.010 |
Why?
| Family Characteristics | 1 | 2004 | 164 | 0.010 |
Why?
| Attention | 1 | 2004 | 443 | 0.010 |
Why?
| Transcription, Genetic | 1 | 2007 | 1355 | 0.010 |
Why?
| Algorithms | 1 | 2008 | 1593 | 0.010 |
Why?
| DNA | 1 | 2007 | 1401 | 0.010 |
Why?
| Double-Blind Method | 1 | 2003 | 1711 | 0.010 |
Why?
| Cognition Disorders | 1 | 2003 | 547 | 0.010 |
Why?
| Arsenates | 1 | 1993 | 1 | 0.010 |
Why?
| Unithiol | 1 | 1993 | 2 | 0.010 |
Why?
| Dimercaprol | 1 | 1993 | 7 | 0.010 |
Why?
| Succimer | 1 | 1993 | 4 | 0.010 |
Why?
| Arsenic | 1 | 1993 | 40 | 0.010 |
Why?
| Drug Evaluation, Preclinical | 1 | 1993 | 187 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 1993 | 418 | 0.010 |
Why?
| Animals | 2 | 1993 | 34133 | 0.010 |
Why?
| In Vitro Techniques | 1 | 1993 | 1130 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 1993 | 2501 | 0.000 |
Why?
| Mice | 1 | 1993 | 15888 | 0.000 |
Why?
|
|
Hopfer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|